09/08/2026
On the surface, medical device compliance in Canada and the U.S. looks similar. In practice, the pathways are built very differently.
In Canada, risk classification (Class I–IV) directly determines licensing requirements and regulatory oversight. Most Class II–IV devices require a Medical Device Licence, backed by quality system evidence and technical documentation tied closely to intended use.
In the U.S., the FDA focuses on regulatory pathways - exemption, 510(k), or PMA - where comparison to predicate devices, clinical evidence, and submission strategy often drive timelines more than device class alone.
A few things manufacturers often underestimate:
• A device’s risk class may change between markets
• Approval in one country doesn’t shorten the process in the other
• Documentation expectations differ, even for identical products
Understanding the nuances between Canadian and U.S. medical device pathways helps manufacturers plan investment, design, and evidence generation with confidence instead of reacting to requirements mid-project.
📩 Have questions about navigating cross-border medical device certification?
Let’s talk: [email protected]
